Cargando…
Organometallic Titanocene–Gold Compounds as Potential Chemotherapeutics in Renal Cancer. Study of their Protein Kinase Inhibitory Properties
[Image: see text] Early–late transition metal TiAu(2) compounds [(η-C(5)H(5))(2)Ti{OC(O)CH(2)PPh(2)AuCl}(2)] (3) and new [(η-C(5)H(5))(2)Ti{OC(O)-4-C(6)H(4)PPh(2)AuCl}(2)] (5) were evaluated as potential anticancer agents in vitro against renal and prostate cancer cell lines. The compounds were sign...
Autores principales: | Fernández-Gallardo, Jacob, Elie, Benelita T., Sulzmaier, Florian J., Sanaú, Mercedes, Ramos, Joe W., Contel, María |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American
Chemical Society
2014
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4245150/ https://www.ncbi.nlm.nih.gov/pubmed/25435644 http://dx.doi.org/10.1021/om500965k |
Ejemplares similares
-
Titanocene–Gold Complexes Containing N-Heterocyclic
Carbene Ligands Inhibit Growth of Prostate, Renal, and Colon Cancers
in Vitro
por: Mui, Yiu Fung, et al.
Publicado: (2016) -
Heterometallic titanium–gold complexes inhibit renal cancer cells in vitro and in vivo
por: Fernández-Gallardo, Jacob, et al.
Publicado: (2015) -
In Vitro and in Vivo Evaluation
of Water-Soluble Iminophosphorane Ruthenium(II) Compounds. A Potential
Chemotherapeutic Agent for Triple Negative Breast Cancer
por: Frik, Malgorzata, et al.
Publicado: (2014) -
Preclinical evaluation of an unconventional ruthenium‐gold‐based chemotherapeutic: RANCE‐1, in clear cell renal cell carcinoma
por: Elie, Benelita T., et al.
Publicado: (2019) -
Enantioselective Hydrogenations with Chiral Titanocenes
por: Vassylyev, Oleksiy, et al.
Publicado: (2005)